enp2 Antibody

Introduction to ENP2 Antibodies

ENP2 antibodies target proteins associated with the ENP2 nomenclature, which refers to distinct biological entities across species. This review focuses on two primary contexts:

• Human ENPP2 (Ectonucleotide Pyrophosphatase/Phosphodiesterase 2), also known as Autotaxin (ATX), a secreted enzyme involved in lysophosphatidic acid (LPA) production .

• Microsporidian EnP2, a spore wall protein critical for endospore formation in parasites like Nosema bombycis and Encephalitozoon cuniculi .

Human ENPP2/ATX

Microsporidian EnP2

Key Antibodies and Their Applications

Validation Standards:

• Genetic strategies (KO cell lines) .

• Immunocapture mass spectrometry .

• Orthogonal methods (e.g., immunofluorescence vs. Western blot) .

ENPP2/ATX in Human Disease

• Cancer: Overexpressed in hepatocellular carcinoma, prostate cancer, and non-small-cell lung cancer . Anti-ENPP2 antibodies inhibit LPA-driven metastasis in preclinical models .

• Fibrosis: ENPP2 knockdown reduces pathological collagen deposition in cardiac microvascular endothelial cells .

Microsporidian EnP2 in Pathogenesis

• Spore Development: EnP2 (EOB13320 in N. bombycis) relocalizes from cytoplasm to endospore during sporulation, facilitating wall assembly .

• Diagnostic Utility: Monoclonal antibody 2B10 enables specific detection of N. bombycis spores in infected silkworms .

Challenges in ENP2 Antibody Use

Future Directions

• Recombinant Antibody Libraries: Microfluidics-enabled screening allows rapid isolation of high-affinity ENPP2 antibodies (e.g., <1 pM affinity anti-SARS-CoV-2 antibodies) .

• Therapeutic Targeting: Antibodies blocking ENPP2’s catalytic site could treat LPA-mediated diseases like fibrosis .

• Diagnostic Development: Engineered EnP2 antibodies may enable point-of-care tests for microsporidiosis .